{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["198(12)"],"submitter":["Fabian A"],"funding":["Universitätsklinikum Schleswig-Holstein - Campus Kiel"],"pubmed_abstract":["<h4>Purpose</h4>Financial toxicity arises in cancer patients from subjective financial distress due to objective financial burden from the disease or treatment. Financial toxicity associates with worse outcomes. It has not been described in cancer patients undergoing radiotherapy in Germany and its publicly funded health system. In this context, we therefore investigated the prevalence of financial toxicity, associated risk factors, and patient preferences on communication of financial burden.<h4>Methods</h4>We conducted a preregistered ( https://doi.org/10.17605/OSF.IO/KH6VX ) cross-sectional study surveying patients at the end of their course of radiotherapy in two institutions. Objective financial burden was assessed by direct costs and loss of income. Financial toxicity was measured by"],"journal":["Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]"],"pagination":["1053-1061"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9700565"],"repository":["biostudies-literature"],"pubmed_title":["Financial toxicity in cancer patients treated with radiotherapy in Germany-a cross-sectional study."],"pmcid":["PMC9700565"],"pubmed_authors":["Domschikowski J","Greiner W","Krug D","Dunst J","Grosu AL","Ruhle A","Bockelmann G","Nicolay NH","Fabian A","Karsten E"],"additional_accession":[]},"is_claimable":false,"name":"Financial toxicity in cancer patients treated with radiotherapy in Germany-a cross-sectional study.","description":"<h4>Purpose</h4>Financial toxicity arises in cancer patients from subjective financial distress due to objective financial burden from the disease or treatment. Financial toxicity associates with worse outcomes. It has not been described in cancer patients undergoing radiotherapy in Germany and its publicly funded health system. In this context, we therefore investigated the prevalence of financial toxicity, associated risk factors, and patient preferences on communication of financial burden.<h4>Methods</h4>We conducted a preregistered ( https://doi.org/10.17605/OSF.IO/KH6VX ) cross-sectional study surveying patients at the end of their course of radiotherapy in two institutions. Objective financial burden was assessed by direct costs and loss of income. Financial toxicity was measured by","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Dec","modification":"2025-04-25T21:03:16.113Z","creation":"2025-04-06T08:34:36.481Z"},"accession":"S-EPMC9700565","cross_references":{"pubmed":["35467099"],"doi":["10.1007/s00066-022-01936-z"]}}